- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannvas Exhibits Cannabis Data AI Technologies at Cantech Conference
Cannvas MedTech Inc. (CSE:MTEC) (Frankfurt:3CM) (OTCPK:CANVF) (“Cannvas” or the “Company”), a leading digital cannabis educator and data company, is pleased to announce it will have a substantial presence at the 2019 Cantech Investment Conference, taking place January 29-30 at the Metro Toronto Convention Centre in the heart of the city’s downtown core.
Cannvas MedTech Inc. (CSE:MTEC) (Frankfurt:3CM) (OTCPK:CANVF) (“Cannvas” or the “Company”), a leading digital cannabis educator and data company, is pleased to announce it will have a substantial presence at the 2019 Cantech Investment Conference, taking place January 29-30 at the Metro Toronto Convention Centre in the heart of the city’s downtown core.
“We are thrilled to be exhibiting our Cannabis Data AI technology and being part of the Cannabis and Big Data Panel. We have a significant presence at this year’s Cantech Investment Conference, and with it the opportunity to signal to investors how our Cannabis Data AI is at the cusp of driving substantial growth in the industry as a major catalyst for licensed producers and dispensaries here in Canada” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc.
Cannvas MedTech will be at booth 622 at this year’s Cantech conference, with speaking engagements scheduled on each day of the conference. On Tuesday, January 29, CEO Shawn Moniz will participate in a discussion panel on the subject of Cannabis and Big Data, moderated by a member of Toronto law firm Fogler Rubinoff LLP. On Wednesday, January 30, Shawn will take to the Paradigm Stage for a featured speaking appearance expected to stress the importance of cannabis analytics in a nascent industry, positioning Cannvas as a leading source of comprehensive and unbiased information on the behaviours of active and potential cannabis consumers across Canada.
While at the conference, the senior management team at Cannvas expects to meet and connect with hundreds of leading Canadian technology companies, schedule private meetings with business leaders and influencers, and learn more about potential partnership opportunities with like-minded organizations.
The Cantech Investment Conference is put on by Cambridge House International, producing North America’s largest resource conferences and Canada’s largest technology investment conference. For 25 years, Cambridge House has produced flagship must-attend events and provided industries with platforms for networking, education and investment discovery. Cantech is a hallmark event attracting investors and media from across North America to meet with Canadian innovation entrepreneurs.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.